商品标签为：'sn-38'
浏览为
排序由
显示 每页
7-乙基-10-羟基喜树碱，7-Ethyl-10-hydroxycamptothecin [SN-38]；≥98% (HPLC), powder
H0165
![图片 7-乙基-10-羟基喜树碱，7-Ethyl-10-hydroxycamptothecin [SN-38]；≥98% (HPLC), powder](https://www.bszh.cn/images/thumbs/0002385_7-10-7-ethyl-10-hydroxycamptothecin-sn-3898-hplc-powder_415.png "显示明细 7-乙基-10-羟基喜树碱，7-Ethyl-10-hydroxycamptothecin [SN-38]；≥98% (HPLC), powder")
别名：(4S)-4,11-二乙基-4,9-二羟基-1H-吡喃酮[3′,4′:6,7]中氮茚[1,2-b]喹啉-3,14(4H,12H)二酮；伊立替康相关化合物B；Irinotecan Related Compound B；7-乙基-10-羟基喜树脂；SN-38, 是拓扑异构酶I抑制剂伊立替康的活性代谢产物, SN-38 (NK012) 抑制DNA合成和RNA 合成的IC50分别为0.077 和 1.3 μM
Empirical Formula (Hill Notation): C22H20N2O5 CAS号: 86639-52-3 分子量: 392.40 MDL编号: MFCD00871873 PubChem化学物质编号: 329815105 NACRES: NA.77
Empirical Formula (Hill Notation): C22H20N2O5 CAS号: 86639-52-3 分子量: 392.40 MDL编号: MFCD00871873 PubChem化学物质编号: 329815105 NACRES: NA.77
¥2,350.00
7-乙基-10-羟基喜树碱，7-Ethyl-10-hydroxycamptothecin [SN-38]；Pharmaceutical Secondary Standard; Certified Reference Material
PHR2718
![图片 7-乙基-10-羟基喜树碱，7-Ethyl-10-hydroxycamptothecin [SN-38]；Pharmaceutical Secondary Standard; Certified Reference Material](https://www.bszh.cn/images/thumbs/0016222_7-10-7-ethyl-10-hydroxycamptothecin-sn-38pharmaceutical-secondary-standard-certified-reference-mater_415.png "显示明细 7-乙基-10-羟基喜树碱，7-Ethyl-10-hydroxycamptothecin [SN-38]；Pharmaceutical Secondary Standard; Certified Reference Material")
别名：伊立替康相关化合物B标准品；Irinotecan Related Compound B；(4S)-4,11-二乙基-4,9-二羟基-1H-吡喃酮[3′,4′:6,7]中氮茚[1,2-b]喹啉-3,14(4H,12H)二酮；(4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione；7-乙基-10-羟基喜树脂；SN-38, 是拓扑异构酶I抑制剂伊立替康的活性代谢产物, SN-38 (NK012) 抑制DNA合成和RNA 合成的IC50分别为0.077 和 1.3 μM
Empirical Formula (Hill Notation): C22H20N2O5 CAS号: 86639-52-3 分子量: 392.40 MDL编号: MFCD00871873
Empirical Formula (Hill Notation): C22H20N2O5 CAS号: 86639-52-3 分子量: 392.40 MDL编号: MFCD00871873
¥5,650.26
